Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Eledon Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- +2 vs. Q4 2022
- Shares held
- 6.24M
- −10.4K (−0.2%) vs. Q4 2022
- Total value
- $14.7M
- +$348.4K (+2.4%) vs. Q4 2022
- New holders
- 7
- 4 more added
- Sold out
- 5
- 4 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 161 | $184.6M |
| Q1 2026 | 121 | $131.2M |
| Q4 2025 | 95 | $66.7M |
| Q3 2025 | 83 | $94.5M |
| Q2 2025 | 85 | $110.7M |
| Q1 2025 | 83 | $130.3M |
| Q4 2024 | 75 | $158.5M |
| Q3 2024 | 33 | $46.0M |
| Q2 2024 | 32 | $48.2M |
| Q1 2024 | 29 | $19.8M |
| Q4 2023 | 29 | $16.5M |
| Q3 2023 | 28 | $12.2M |
| Q2 2023 | 33 | $12.7M |
| Q1 2023 | 30 | $14.7M |
| Q4 2022 | 28 | $14.4M |
| Q3 2022 | 31 | $17.3M |
| Q2 2022 | 31 | $15.9M |
| Q1 2022 | 32 | $27.6M |
| Q4 2021 | 36 | $34.7M |
| Q3 2021 | 35 | $52.1M |
| Q2 2021 | 34 | $74.5M |
| Q1 2021 | 34 | $89.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Eledon Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 69 | $0 | 0.00% | +69 | New |
| Wells Fargo & Company | 86 | $203 | 0.00% | +2+2.4% | Added |
| UBS Group AG | 456 | $1.08K | 0.00% | −3,536−88.6% | Reduced |
| Group One Trading, L.P. | 600 | $1.42K | 0.00% | +600 | New |
| Ameritas Advisory Services, LLC | 1,000 | $2.27K | 0.00% | +1,000 | New |
| Tower Research Capital LLC (TRC) | 6,251 | $15.0K | 0.00% | +4,353+229.3% | Added |
| Millennium Management LLC | 12,605 | $30.0K | 0.00% | +12,605 | New |
| Veritable, L.P. | 13,029 | $30.7K | 0.00% | +13,029 | New |
| Charles Schwab Investment Management Inc | 14,987 | $35.4K | 0.00% | +14,987 | New |
| Mercer Global Advisors Inc | 16,726 | $39.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 17,586 | $41.5K | 0.00% | −4,051−18.7% | Reduced |
| Dimensional Fund Advisors LP | 17,954 | $42.4K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 22,050 | $52.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 25,100 | $59.2K | 0.00% | −500−2.0% | Reduced |
| SVB Financial Group | 26,942 | $63.6K | 0.12% | −13,671−33.7% | Reduced |
| Northern Trust Corp | 30,053 | $70.9K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 30,810 | $72.7K | 0.00% | +30,810 | New |
| Renaissance Technologies LLC | 32,173 | $76.0K | 0.00% | +2,500+8.4% | Added |
| State Street Corp | 44,692 | $105.5K | 0.00% | 00.0% | Unchanged |
| Ingalls & Snyder LLC | 50,849 | $120.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 52,568 | $124.1K | 0.00% | +798+1.5% | Added |
| Jmac Enterprises LLC | 54,538 | $128.7K | 0.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 129,151 | $304.8K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 221,830 | $523.5K | 0.22% | 00.0% | Unchanged |
| CM Management, LLC | 234,800 | $554.0K | 0.66% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 443,001 | $1.05M | 0.00% | 00.0% | Unchanged |
| Woodline Partners LP | 516,675 | $1.22M | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 679,557 | $1.60M | 0.00% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,217,882 | $2.87M | 0.19% | 00.0% | Unchanged |
| BVF Inc | 2,326,710 | $5.49M | 0.20% | 00.0% | Unchanged |
| Eversept Partners, LP | 0 | $0 | 0.00% | −67,743−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −1,666−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |